Novel Therapies for Essential Tremor - Tabular View

Tracking Information

First Received Date ^ICMJE

July 3, 2001

Last Updated Date

January 20, 2009

Start Date ^ICMJE

October 2000

Primary Completion Date

Current Primary Outcome Measures ^ICMJE

Original Primary Outcome Measures ^ICMJE

Change History

Complete list of historical versions of study NCT00018564 on ClinicalTrials.gov Archive Site

Current Secondary Outcome Measures ^ICMJE

Original Secondary Outcome Measures ^ICMJE

Descriptive Information

Brief Title ^ICMJE

Novel Therapies for Essential Tremor

Official Title ^ICMJE

Novel Therapies for Essential Tremor

Brief Summary

This clinical research program is designed to evaluate medications as new treatments for essential tremor. Essential tremor is a common condition with few available therapies.

Detailed Description

Each medication will be evaluated for effectiveness against tremor in a randomized, placebo-controlled, cross-over, double blind clinical research trial. Tremor will be assessed with accepted rating scales and accelerometry

Study Phase

Phase III

Study Type ^ICMJE

Interventional

Study Design ^ICMJE

Treatment, Randomized, Double-Blind, Placebo Control, Efficacy Study

Condition ^ICMJE

Essential Tremor

Intervention ^ICMJE

Drug: treatments for essential tremor

Study Arms / Comparison Groups

Publications *

* Includes publications given by the data provider as well as publications identified by National Clinical Trials Identifier (NCT ID) in Medline.

Recruitment Information

Recruitment Status ^ICMJE

Completed

Enrollment ^ICMJE

Completion Date

September 2003

Primary Completion Date

Eligibility Criteria ^ICMJE

Diagnosis of essential tremor.
Tremor rating scale score 3 or one or both upper extremities
Unsatisfactory response to primidone or to propanolol
Not taking tremor-inducing drug
Able to comply with visits

Gender

Both

Ages

18 Years and older

Accepts Healthy Volunteers

Contacts ^ICMJE

Contact information is only displayed when the study is recruiting subjects

Location Countries ^ICMJE

United States

Administrative Information

NCT ID ^ICMJE

NCT00018564

Responsible Party

Study ID Numbers ^ICMJE

NEUD-048-00S

Study Sponsor ^ICMJE

Department of Veterans Affairs

Collaborators ^ICMJE

Investigators ^ICMJE

Investigator:

Fredricka Martin, Ph.D.

Information Provided By

Department of Veterans Affairs

Verification Date

December 2004

^ICMJE Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP